Loading clinical trials...
Loading clinical trials...
Study of a Short Course of Neoadjuvant Gleevec (Imatinib Mesylate) in Dermatofibrosarcoma Protuberans
Conditions
Interventions
imatinib mesylate
Locations
4
United States
H. Lee Moffitt Cancer Center
Tampa, Florida, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
Pennsylvania Onc/Hem Assoc.
Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
May 1, 2006
Primary Completion Date
September 1, 2009
Completion Date
September 1, 2009
Last Updated
March 29, 2012
NCT00346164
NCT00659360
NCT00084630
Lead Sponsor
Sarcoma Alliance for Research through Collaboration
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions